twice per day • Weeks 1 to 4: 0.25 mg Wegovy comes as a solution inside prefilled, single-use pens given as a subcutaneous injection. When you’re first prescribed Wegovy, a healthcare ...

Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...

The drug, called amycretin and codenamed NN9487, is a dual agonist that targets both GLP-1 and amylin and is being developed in both oral and subcutaneous injection formulations. The oral form has ...

Panelists discuss how subcutaneous (SubQ) drug formulations offer practical value by significantly reducing treatment times, easing staffing pressures, and enhancing efficiency in oncology practices, ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Wegovy (semaglutide) is a prescription drug used for weight loss and to reduce the risk of serious cardiovascular issues. Wegovy can interact with some supplements and other medications, such as ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk. The full data from the 751-subject SURMOUNT-5 ...

Here’s what you need to know. Ozempic is the brand name for a medicine called semaglutide, which is sold under the brand name Wegovy, too. Ozempic has FDA approval to treat type 2 diabetes.